GIP
SGYP

Granite Investment Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Granite Investment Partners’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-101,842
Closed -$186K – 340
2018
Q1 		$186K Sell
101,842
-181,673
-64% -$384K 0.01% 286
2017
Q4 		$632K Buy
+283,515
New +$705K 0.04% 262

Other funds holding SGYP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Granite Investment Partners's SGYP Position: Q2 2018 in Review

Granite Investment Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2018, closing a stake of 101,842 shares — an estimated $186K sold.

Granite Investment Partners first reported a position in SGYP in Q4 2017 and held it in 2 quarters. The position peaked at $632K in Q4 2017. 137 funds tracked by Wall St. Rank hold SGYP as of Q2 2018.

  • Granite Investment Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2018 after selling out during the quarter.
  • Granite Investment Partners sold 101,842 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2018, an estimated $186K.
  • Granite Investment Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2017 and held it in 2 quarters.
  • Granite Investment Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $632K in Q4 2017.
  • 137 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2018.

Based on Granite Investment Partners's 13F filing for Q2 2018, filed 6 Aug 2018.